Results 201 to 210 of about 1,299,020 (330)

Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study [PDF]

Amyloidosis is a disease characterized by the deposition of protein fibrils. Cardiac involvement is a significant factor in determining prognosis. This study aimed to examine the clinical profile, outcomes, and long-term mortality rates in patients with ...
Ingebrigtsen, Andreas, Larsen, Terje Hjalmar, Reikvam, Håkon, Saeed, Sahrai   +3 more
core   +1 more source

Ventilatory efficiency in cardiac amyloidosis—A systematic review and meta‐analysis

Physiological Reports, Volume 13, Issue 9, May 2025.
Exercise limitations and ventilatory efficiency in cardiac amyloidosis. This illustration summarizes CPET findings in cardiac amyloidosis. Patients with transthyretin amyloidosis, both wild‐type and variant, exhibit elevated VE/VCO₂ slopes, indicating ventilatory inefficiency. Light‐chain amyloidosis patients are younger and show comparatively lower VE/
Robin Willixhofer, Elisabetta Salvioni, Nicolò Capra, Mauro Contini, Jeness Campodonico, Piergiuseppe Agostoni   +5 more
wiley   +1 more source

Myocardial Mechanics and Valvular and Vascular Abnormalities in Cardiac Amyloidosis [PDF]

Cardiac amyloidosis is an infiltrative disease primarily caused by extracellular tissue deposition of amyloid fibrils in the myocardial interstitium.
Nemes Attila
core   +1 more source

Intracellular cardiac amyloidosis in familiar amyloid polyneuropathy of the Portuguese type [PDF]

, 2002
Mandy Otto, Terkel Hansen, Jörg Kriegsmann   +2 more
openalex   +1 more source

Automatic diagnosis of cardiac magnetic resonance images based on semi-supervised learning [PDF]

arXiv
Cardiac magnetic resonance imaging (MRI) is a pivotal tool for assessing cardiac function. Precise segmentation of cardiac structures is imperative for accurate cardiac functional evaluation. This paper introduces a semi-supervised model for automatic segmentation of cardiac images and auxiliary diagnosis.
arxiv  

SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?

European Journal of Clinical Investigation, EarlyView.
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, Aldo Bonaventura   +3 more
wiley   +1 more source

Diagnosing Smoldering Multiple Myeloma and Light Chain Amyloidosis in the Setting of Severe Transthyretin Amyloid Cardiomyopathy and Extracardiac Sarcoidosis

Annals of Internal Medicine: Clinical Cases
Light chain (AL) amyloidosis involves deposition of monoclonal immunoglobulin light chain-derived amyloid fibrils, whereas ATTR amyloidosis involves deposition of insoluble antiparallel beta-pleated protein within tissues, leading to organ-specific ...
Robert A. Churchill, Andrew Rosenbaum
doaj   +1 more source

Cardiac amyloidosis imaging

, 1970
Diego Pérez de Arenaza, Sergio Baratta, Roxana Campisi, Miguel Cerdá, Adela Aguirre, Eugenia Villanueva, Alberto Fernández, César Belziti   +7 more
openalex   +2 more sources

Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis

, 1987
Rodney H. Falk, Jonathan F. Plehn, Thomas F. Deering, Edgar C. Schick, Paul Boinay, Alan Rubinow, Martha Skinner, Alan S. Cohen   +7 more
openalex   +1 more source

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation [PDF]

, 2004
Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, Martha Q. Lacy, Mary F. Burritt, Terry M. Therneau, Joseph P. McConnell, Mark R. Litzow, Dennis A. Gastineau, Ayalew Tefferi, David J. Inwards, Ivana N. Micallef, Stephen M. Ansell, Luis F. Porrata, Michelle A. Elliott, William J. Hogan, S. Vincent Rajkumar, Rafaël Fonseca, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Steven R. Zeldenrust, Denise S. Snow, S. R. Hayman, Christopher G.A. McGregor, Allan S. Jaffe   +25 more
openalex   +1 more source